G- But the company will be able to resubmit only if RI data becomes available which requires interim stop. If a recommendation is to continue, resubmission is not an option as the company will continue to be blinded to the data. Moreover, futility won't be ruled out either as interim won't analyze for futility.
Appears you are saying AMRN responds to ANCHOR CRL with R-IT data, but R-IT supersedes ANCHOR, it's a much broader indication with a different label - surely that requires a new and separate sNDA, not a modification/retrofit of ANCHOR sNDA? That's what nearly everyone here has been claiming and believing for a long time (except BB), including yourself IIRC - that is ANCHOR dead, end of story.
News 
Market Data 
Discover 
AI
